Cheilitis

05/01/2010 - "The most prevalent mucocutaneous adverse reaction associated with isotretinoin therapy was cheilitis, reported by 94% of the patients. "
07/01/1998 - "One received oral isotretinoin 1 mg/kg per day, but was unable to tolerate the adverse effects of cheilitis and developed hyperlipidaemia. "
08/01/1995 - "All patients who received 13-cis-retinoic acid developed cheilitis, but no bone marrow depression occurred in these patients. "
12/22/1994 - "The only toxic effect of isotretinoin therapy was cheilitis in two patients. "
04/01/1992 - "A high proportion of all patients suffered inflammatory side-effects of isotretinoin such as cheilitis and nasal vestibulitis, with their maximum severities being recorded 2 months after starting isotretinoin. "

01/01/1995 - "The side effects of etretinate (cheilitis, dryness of mucous membranes and skin) were acceptable to most patients. "
09/01/1985 - "Surprisingly, the kinetics of disappearance of the most frequent side effect, cheilitis, was the same in the Tigason group and in the placebo group. "
01/01/1989 - "The disease should be differentiated from erosive leukoplakia, exfoliative cheilitis, etc. Tigason therapy has been found the most effective for this condition."
06/01/1989 - "They were similar to those of etretinate therapy; cheilitis, peeling of palms and soles, and alopecia occurred most frequently. "
05/01/1989 - "The most common adverse effects of etretinate are cheilitis, alopecia, desquamation of the skin, drying of mucous membranes, and pruritus. "

10/01/2015 - "Psoriatic cheilitis: a report of 2 cases treated successfully with topical tacrolimus and a review of the literature."
06/01/2013 - "Successful treatment with 308-nm monochromatic excimer light and subsequent tacrolimus 0.03% ointment in refractory plasma cell cheilitis."
01/01/2011 - "We present herein two cases of plasma cell cheilitis, in which topical tacrolimus showed beneficial effects, suggesting that this immunomodulatory agent is a promising option for plasma cell cheilitis."
01/01/2011 - "Successful treatment of plasma cell cheilitis with topical tacrolimus: report of two cases."
05/01/2010 - "She was diagnosed as having plasma cell cheilitis, and was successfully treated with 0.03% topical tacrolimus ointment."

05/01/1989 - "In a group of 535 children and 103 adult patients with atopic dermatitis no differences were observed between persons with normal and raised IgE level with respect to incidence of lesions in the first or the first three months of life, the total number of the positive RAST results and the most intense reactions, that is 4 degrees, the percent of helper and suppressor T-cells, duration of remission, darkening of lower eyelids, cheilitis, involvement of the hands, the feet, the elbow flexures or knee flexures. "
02/01/1991 - "A positive history in both parents and/or their families was associated with higher IgE titres, earlier appearance of skin changes, more frequent occurrence of urticaria, allergic respiratory diseases, cheilitis, and, in women, nipple eczema. "
07/01/2011 - "Out of 20 examined minor criteria, most common was cutaneous infection in 168(80.0%) patients followed by coursed influenced by environmental factor in 140(66.7%), high IgE level in 126(60.0%), intolerance of wool in 105(50.0%), xerosis in 92(43.8%), infra-orbital fold in 83(39.5%), ichthyosis in 72(34.3%), early age of onset in 65(31.0%), itch on sweating in 56(26.7%), palmary hyperlinearity in 52(24.8%), food hypersensitivity in 40(19.0%), keratosis pilaris in 31(14.8%), pityriasis alba in 30(14.3%), facial erythema in 25(1.9%), cheilitis in 22(10.5%), hand eczema in 19(9.0%), foot eczema in 16(7.6%), intolerance of lipid solvent in 14(6.7% ), scalp scaling in 11(5.2%) and infra-auricular fissure in 10(4.8%). "
07/01/2011 - "Out of 33 sub-criteria of Hanifin and Rajka, 20 of which were examined encompassed tendency towards cutaneous infection, environmental factor, high IgE level, intolerance of wool, xerosis, infra-orbital fold, ichthyosis, early age of onset, itch on sweating, palmer hyperlinearity, food hypersensitivity, keratosis pilaris, pityriasis alba, facial erythema, cheilitis, hand eczema, foot eczema, intolerance of lipid solvent, scalp scaling and infra-auricular fissure. "

01/01/2010 - "On presentation of a clinical picture of PCT-like photosensitivity in a patient on voriconazole, laboratory investigations should be performed routinely to rule out true PCT, even in cases of associated cheilitis."
01/01/2010 - "This patient had both voriconazole-induced superficial cheilitis and a true PCT which seemed related to the same drug. "
01/01/2010 - "We report a case of true PCT associated with cheilitis, both occurring soon after the introduction of voriconazole and partially disappearing after withdrawal of this drug. "
11/01/2001 - "Both erythema and cheilitis resolved after discontinuation of voriconazole. "
05/01/2005 - "The patient's blisters, erythema, and cheilitis resolved after discontinuation of voriconazole. "

12/01/2009 - "Successful treatment of plasma cell cheilitis with topical calcineurin inhibitors."
01/01/2011 - "Recent reports show that topical calcineurin inhibitors are effective for plasma cell cheilitis, balanitis, and vulvitis. "

05/01/1981 - "Retinol was highly efficacious in doses of 300,000 units for women and 400,000 to 500,000 units for men, toxicity was slight and limited mainly to skin (xerosis) and mucous membranes (cheilitis). "
07/01/1996 - "Topical vitamin A in exfoliative cheilitis."

01/01/2010 - "Withdrawal of voriconazole (replaced by itraconazole) resulted in complete disappearance of the cheilitis but incomplete remission of the PCT. "

07/01/1989 - "We report two cases of patients with cheilitis granulomatosis treated successfully with tranilast and ketotifen, both of which are known to be potent inhibitors or mediator release from mast cells. "

03/01/1986 - "Clofazimine--an effective treatment for Melkersson-Rosenthal syndrome or Miescher's cheilitis."

01/01/2001 - "Laser therapy and PDT have shown good results in the curative treatment of actinic keratoses, superficial basal cell carcinoma, Bowen's disease and cheilitis actinica. "

11/01/2010 - "The complete remission rate is increased and survival time is prolonged in APL patients who receive chemotherapy plus ATRA, whereas ATRA syndrome and other ATRA-related adverse effects including pseudo tumor cerebri, headache, severe bone pain, mucosal and skin dryness, hypercholesterolemia, and cheilitis may be observed especially during induction phase of the treatment. "

01/01/2012 - "The associated cheilitis has dramatically reduced after treatment of the gingival lesion."

06/01/2013 - "Multivariate logistic regression analyses were performed to measure the association between HAART and OC, with pseudomembranous [PC], erythematous [EC], and angular cheilitis [AC]) adjusted for HIV-related diseases, smoking, alcohol consumption, injecting and non-injecting drug use. "
01/01/2001 - "A variety of exfoliative cheilitis has been observed in reactive HIV-1 patients subjected to high activity antiretroviral therapy (HAART). "
01/01/2001 - "Eruptive cheilitis: a new adverse effect in reactive HIV-positive patients subjected to high activity antiretroviral therapy (HAART). "
07/01/2012 - "Patients on HAART comprised about 61.9% and these were found to have reduced risk for development of such oral lesions as angular cheilitis (OR=0.76; 95% CI=0.56-1.02; P=0.03), pseudomembranous candidiasis (OR=0.71; 95% CI=0.54-0.94; P=0.024) and HIV-gingivitis (OR=0.59; 95% CI=0.46-0.75; P=0.001). "
01/01/2015 - "The most common oral lesions detected in patients on HAART were increased oral hyper-pigmentation (14%), recurrent aphthous stomatitis (8%), non-specific ulcerations (4%), pseudo-membranous candidiasis (2%), periodontitis (2%) and xerostomia (2%), whereas in non HAART oral hyperpigmentation (10%), pseudo-membranous candidiasis (8%), angular cheilitis (4%), and erythematous candidiasis (4%) and Periodontitis (14%) were more prevalent. "

11/01/1999 - "Allergic contact cheilitis due to effervescent dental cleanser: combined responsibilities of the allergen persulfate and prosthesis porosity."
10/01/2007 - "Also described is a method to incorporate a canula into the denture prosthesis to channel the saliva toward the oropharyngeal area for geriatric and handicapped patients who suffer from chronic drooling and angular cheilitis."
05/01/2008 - "Angular cheilitis, denture stomatitis and inflammatory fibrous hyperplasia were statistically associated with prosthesis use. "